CCG215022 is primarily investigated for its potential applications in medical research, particularly in the field of cardiovascular diseases. It functions as a selective inhibitor of G-protein-coupled receptor kinase 2 (GRK2), which plays a critical role in regulating cardiac function. By inhibiting GRK2, CCG215022 helps in enhancing cardiac contractility and improving heart function, making it a promising candidate for treating heart failure and related conditions. Additionally, its role in modulating cell signaling pathways makes it a valuable tool in studying the mechanisms underlying cardiovascular disorders and exploring new therapeutic strategies.